Immutep (IMMP) Stock Price

$1.92 0%

Sign up
to add to portfolio

AI Score

Hold
  • Alternative

    6
  • Fundamental

    7
  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Immutep, AI stock picks, stock alerts and much more.

Sign up

IMMP AI Stock Analysis

AI stock analysis for IMMP is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Immutep (IMMP) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Immutep (IMMP) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Immutep (IMMP), currently trading at $1.92, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About IMMP

LSE
  • Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates.

  • Symbol

    IMMP

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    279.5M

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX
$21.62
2%
6
INO Inovio Pharmaceuticals
INO
$2.24
0.9%
2
MRNA Moderna
MRNA
$35.53
5.3%
4
AVXL Anavex Life Sciences
AVXL
$8.35
3.8%
6
BBIO BridgeBio Pharma
BBIO
$36.85
0.1%
6

IMMP Alternative Data

Web Traffic

Immutep receives an estimated 5932 monthly visitors to immutep.com.

  • Web Traffic

    5932

  • Change from Previous Month

    7.6%

  • 3 Month Change

    2.4%

  • YoY Change

    2.4%

News Mentions

Immutep was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Reddit Mentions

Immutep has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

Twitter Followers

Immutep has 1,969 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.5% over the last month.

  • Twitter Followers

    1969

  • Daily Change

    0%

  • 1 Month Change

    0.5%

  • 3 Month Change

    1.5%

Facebook Engagement

Immutep has engaged 0 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    0

  • Daily Change

    0%

  • 1 Month Change

    100%

  • 3 Month Change

    0%

Youtube Subscribers

Immutep has 174 subscribers on its main Youtube channel, down by -0.6% over the last month.

  • Youtube Subscribers

    174

  • Daily Change

    0%

  • 1 Month Change

    0.6%

  • 3 Month Change

    0.6%

LinkedIn Followers

4,870 are following Immutep on LinkedIn, up by 2.1% over the last month.

  • LinkedIn Followers

    4870

  • Daily Change

    0.1%

  • 1 Month Change

    2.1%

  • 3 Month Change

    5.7%

Job Postings

Immutep currenly has an estimated 1 open job postings.

  • Job Postings

    1

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

LinkedIn Employees

According to LinkedIn, Immutep has 49 employees, up by 2.1% over the last month.

  • LinkedIn Employees

    49

  • Daily Change

    0%

  • 1 Month Change

    2.1%

  • 3 Month Change

    0%

IMMP Financials

IMMP Key Metrics
  • Total Revenue

    A$1.7M

  • Net Income

    -A$21.5M

  • Earnings per Share

    -A$0.0177

  • Free cash flow

    -A$16.4M

  • EBITDA

    -A$22.3M

  • EBITDA Ratio

    -12.9083

  • Total Assets

    A$201.6M

IMMP 2-year Revenue & Income
IMMP 2-year Free Cash Flow

IMMP Technicals

IMMP SMA
IMMP RSI

FAQ

What's the current price of Immutep (IMMP) Stock?
The price of an Immutep (IMMP) share is $1.92.

What's the market cap of Immutep?
The current market cap of Immutep is 279.5M.

Should I buy or sell IMMP?
Immutep shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Immutep is better viewed as a hold or accumulate position while waiting for further developments.

Is Immutep a good investment?
The current analysis of Immutep's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Immutep's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Immutep (IMMP) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Immutep stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Immutep (IMMP) that investors often compare it to?
Immutep (IMMP) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Immutep's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Immutep's stock price to be around $1.96 in 2026. Starting from the current price of $1.92, this represents a 2.1% change in price, indicating a neutral outlook for the stock.

How to buy Immutep (IMMP) Stock?
Immutep stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Immutep shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.